Ticker
IMNMCompany Name
IMMUNOME INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -185.92M | -20.42% | $ 910.49M |
3/31/2025 | $ -161.35M | -23.35% | $ 690.88M |
12/31/2024 | $ -117.97M | -15.83% | $ 745.17M |
9/30/2024 | $ -92.59M | -12.8% | $ 723.41M |
6/30/2024 | $ -65.53M | -8.63% | $ 759.09M |
3/31/2024 | $ -45.8M | -5.19% | $ 882.74M |
12/31/2023 | $ -8.4M | -0.57% | $ 1.47B |
9/30/2023 | $ 2.65M | 0.73% | $ 365.77M |
6/30/2023 | $ 3.73M | 4.35% | $ 85.91M |
3/31/2023 | $ 1.51M | 2.29% | $ 65.96M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for IMMUNOME INC is calculated as follows: FCF [ $ 0 ] / Market Cap [ $ 120.49M ]
(=) FCF Yield [ 0% ]
Minimum
Mar 31, 2022
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.59% |
median | 3.22% |
std | 11.38% |